Furthermore, MC38‐tumor‐infiltrating cDC1 also showed upregulated CD40, CD80, CD86, and MHC‐II expression after RA and anti‐PD‐1 combination treatment (Figure 7H–K). This evidence concerns the gene CD80 and neoplasm.